Position in GILD
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$2,775,128,218
+$157,976,093 QoQ
Shares Held
21,965,555
+3.0% QoQ
Ownership
1.77%
of shares outstanding
% of Portfolio
0.28%
of 13F equity value
Holder Rank
#12
of 2,258 holders
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026NORGES BANK holds $48,449,655,630 across 13 Drug Manufacturers - General names. GILD ranks #6 (5.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
11,471,413 | $13,759,158,041 | |
| 2 | JNJ |
Johnson & Johnson
|
31,825,084 | $8,082,616,583 | |
| 3 | ABBV |
AbbVie Inc.
|
25,554,538 | $6,430,543,942 | |
| 4 | AZN |
Astrazeneca PLC
|
33,864,172 | $6,421,324,294 | |
| 5 | MRK |
Merck & Co., Inc.
|
36,983,784 | $4,752,416,244 | |
| 6 | GILD |
Gilead Sciences, Inc.
This page
|
21,965,555 | $2,775,128,218 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
36,866,658 | $2,124,256,833 | |
| 8 | AMGN |
Amgen Inc
|
5,625,584 | $2,037,136,478 |
All Filings in GILD
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,775,128,218 | 21,965,555 | Shares | Sole | 2026-08-12 | |
| 2025-12-31 | $2,617,152,125 | 21,322,732 | Shares | Sole | 2026-02-10 | |
| 2025-06-30 | $2,150,268,436 | 19,394,502 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $2,224,843,510 | 19,855,810 | Shares | Sole | 2026-05-11 | |
| 2024-12-31 | $1,789,254,008 | 19,370,510 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $1,484,241,821 | 17,703,266 | Shares | Sole | 2025-11-12 | |
| 2024-06-30 | $1,193,063,200 | 17,389,057 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $1,264,295,000 | 17,260,000 | Shares | Sole | 2025-05-14 | |
| 2023-12-31 | $1,301,623,719 | 16,067,445 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $1,099,709,652 | 14,674,535 | Shares | Sole | 2024-11-13 | |
| 2023-06-30 | $1,117,368,335 | 14,498,097 | Shares | Sole | 2024-08-14 | |
| 2023-03-31 | $1,172,354,235 | 14,129,857 | Shares | Sole | 2024-05-15 | |
| 2022-12-31 | $1,115,186,263 | 12,989,939 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $809,713,945 | 13,125,530 | Shares | Sole | 2023-11-13 | |
| 2022-06-30 | $760,143,459 | 12,298,066 | Shares | Sole | 2023-08-14 | |
| 2022-03-31 | $735,853,076 | 12,377,680 | Shares | Sole | 2023-05-12 | |
| 2021-12-31 | $950,910,798 | 13,096,141 | Shares | Sole | 2022-03-09 | |
| 2021-09-30 | $918,574,020 | 13,150,666 | Shares | Sole | 2022-11-14 | |
| 2021-06-30 | $915,937,640 | 13,301,447 | Shares | Sole | 2022-08-15 | |
| 2021-03-31 | $893,217,169 | 13,820,473 | Shares | Sole | 2022-05-09 | |
| 2020-12-31 | $767,547,943 | 13,174,527 | Shares | Sole | 2021-03-02 | |
| 2020-09-30 | $836,761,664 | 13,241,995 | Shares | Sole | 2021-11-12 | |
| 2020-06-30 | $994,613,305 | 12,927,129 | Shares | Sole | 2021-08-13 | |
| 2020-03-31 | $1,060,593,281 | 14,186,641 | Shares | Sole | 2021-05-07 | |
| No filing history on record for this holder in this stock. | ||||||